Matches in SemOpenAlex for { <https://semopenalex.org/work/W4252275629> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W4252275629 endingPage "535" @default.
- W4252275629 startingPage "535" @default.
- W4252275629 abstract "Cancer Biotherapy & RadiopharmaceuticalsVol. 36, No. 6 RetractionsOpen AccessRetraction of: MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway (doi: 10.1089/cbr.2017.2386)This article retracts the following:Retracted: MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling PathwayPublished Online:23 Jul 2021https://doi.org/10.1089/cbr.2017.2386.retractAboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail Cancer Biotherapy and Radiopharmaceuticals officially retracts the paper entitled, “MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway,” by Hong Dai, Chunmei Wang, Zhihai Yu, Donglin He, Kun Yu, Yin Liu, and Sheng Wang (Cancer Biother Radiopharm 2018;33(3):103–109. doi: 10.1089/cbr.2017.2386) due to the authors' admission that the paper was submitted by a paper mill. A message from the corresponding author reads as follows: “I'm very sorry to tell you that some of the experiments in this paper were delegated to an outsourced laboratories inc. because the experimental conditions are limited in our affiliation. The terrible thing is that the laboratories inc. has been found out experimental misconduct. Unfortunately, our paper is involved in. We have to apply for withdrawal of this paper, which is also under investigation of our affiliation.” [sic]The Editor and Publisher of Cancer Biotherapy and Radiopharmaceuticals are committed to preserving the scientific literature and the community it serves and does not tolerate any violations of scientific misconduct.FiguresReferencesRelatedDetailsRelated articlesRetracted: MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway1 Apr 2018Cancer Biotherapy & Radiopharmaceuticals Volume 36Issue 6Aug 2021 InformationCopyright 2021, Mary Ann Liebert, Inc., publishersTo cite this article:Retraction of: MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway (doi: 10.1089/cbr.2017.2386).Cancer Biotherapy and Radiopharmaceuticals.Aug 2021.535-535.http://doi.org/10.1089/cbr.2017.2386.retractcreative commons licensePublished in Volume: 36 Issue 6: July 23, 2021PDF download" @default.
- W4252275629 created "2022-05-12" @default.
- W4252275629 date "2021-08-01" @default.
- W4252275629 modified "2023-09-30" @default.
- W4252275629 title "Retraction of: MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway (doi: 10.1089/cbr.2017.2386)" @default.
- W4252275629 doi "https://doi.org/10.1089/cbr.2017.2386.retract" @default.
- W4252275629 hasPublicationYear "2021" @default.
- W4252275629 type Work @default.
- W4252275629 citedByCount "0" @default.
- W4252275629 crossrefType "journal-article" @default.
- W4252275629 hasBestOaLocation W42522756292 @default.
- W4252275629 hasConcept C121608353 @default.
- W4252275629 hasConcept C126322002 @default.
- W4252275629 hasConcept C190283241 @default.
- W4252275629 hasConcept C2778923194 @default.
- W4252275629 hasConcept C2780192828 @default.
- W4252275629 hasConcept C502942594 @default.
- W4252275629 hasConcept C55493867 @default.
- W4252275629 hasConcept C62112901 @default.
- W4252275629 hasConcept C62478195 @default.
- W4252275629 hasConcept C71924100 @default.
- W4252275629 hasConcept C86803240 @default.
- W4252275629 hasConcept C95444343 @default.
- W4252275629 hasConcept C96232424 @default.
- W4252275629 hasConceptScore W4252275629C121608353 @default.
- W4252275629 hasConceptScore W4252275629C126322002 @default.
- W4252275629 hasConceptScore W4252275629C190283241 @default.
- W4252275629 hasConceptScore W4252275629C2778923194 @default.
- W4252275629 hasConceptScore W4252275629C2780192828 @default.
- W4252275629 hasConceptScore W4252275629C502942594 @default.
- W4252275629 hasConceptScore W4252275629C55493867 @default.
- W4252275629 hasConceptScore W4252275629C62112901 @default.
- W4252275629 hasConceptScore W4252275629C62478195 @default.
- W4252275629 hasConceptScore W4252275629C71924100 @default.
- W4252275629 hasConceptScore W4252275629C86803240 @default.
- W4252275629 hasConceptScore W4252275629C95444343 @default.
- W4252275629 hasConceptScore W4252275629C96232424 @default.
- W4252275629 hasIssue "6" @default.
- W4252275629 hasLocation W42522756291 @default.
- W4252275629 hasLocation W42522756292 @default.
- W4252275629 hasOpenAccess W4252275629 @default.
- W4252275629 hasPrimaryLocation W42522756291 @default.
- W4252275629 hasRelatedWork W2320970371 @default.
- W4252275629 hasRelatedWork W2370523994 @default.
- W4252275629 hasRelatedWork W2386605958 @default.
- W4252275629 hasRelatedWork W2386809885 @default.
- W4252275629 hasRelatedWork W2501960686 @default.
- W4252275629 hasRelatedWork W2569030526 @default.
- W4252275629 hasRelatedWork W2763585477 @default.
- W4252275629 hasRelatedWork W2794327676 @default.
- W4252275629 hasRelatedWork W3012168770 @default.
- W4252275629 hasRelatedWork W4287948124 @default.
- W4252275629 hasVolume "36" @default.
- W4252275629 isParatext "false" @default.
- W4252275629 isRetracted "false" @default.
- W4252275629 workType "article" @default.